| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |